HomeEditorsChoice

1. AxiChrom™ Chromatography Columns 10/17/2011

   The AxiChrom™ column platform is a revolutionary concept in column chromatography that simplifies column handling at all scales from process development to full-scale production.

2. Process Development 1/25/2024

   EirGenix is a contract development and manufacturing organization that performs high quality and cost-effective services supporting our clients in development, analytical testing, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing

   EirGenix has strong process development capabilities in both microbial and mammalian systems to provide our clients process development, process optimization, and process troubleshooting. We have successfully delivered results to meet clients’ requirement in product productivity, product quality, and process cost effectiveness. Our previous project experience includes recombinant proteins, plasmid DNA, fusion proteins, monoclonal antibodies, and biosimilars.

3. Raising The Bar On Microbial Expression And Manufacturability 11/23/2022

   KBI uses an early optimization workflow to ensure manufacturing success. As a result, more molecules are manufactured using an E. Coli expression system than ever before.

4. Pharmaceutical Development 4/24/2023

   Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

5. Scale Your Vaccine With Path-To-PAD 3/1/2024

   The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.

6. Process Development 8/15/2023

   In cell and gene therapies, the process is the product. We have deep expertise developing and scaling processes for cell therapies and viral vectors, including lentiviral vectors and AAV.

7. End-To-End Ophthalmic Drug Development Solutions 4/9/2024

   As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

8. Improving Manufacturing Costs And Patient Safety While Reducing Regulatory Concerns 2/14/2023

   Apply for the Nanoplasmid AAV Construct Giveaway, and you may be awarded a free plasmid retrofit of your construct into the Nanoplasmid vector system. To apply, submit the form with an optional brief abstract that includes preliminary data and a project proposal. Awards will be granted monthly from March to August. Apply today and discover the Power of Small.